Literature DB >> 22155483

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.

Hirosha Geekiyanage1, Gregory A Jicha, Peter T Nelson, Christina Chan.   

Abstract

There is an urgent need to identify non-invasive biomarkers for the detection of sporadic Alzheimer's disease (AD). We previously studied microRNAs (miRNAs) in AD autopsy brain samples and reported a connection between miR-137, -181c, -9, -29a/b and AD, through the regulation of ceramides. In this study, the potential role of these miRNAs as diagnostic markers for AD was investigated. We identified that these miRNAs were down-regulated in the blood serum of probable AD patients. The levels of these miRNAs were also reduced in the serum of AD risk factor models. Although the ability of these miRNAs to conclusively diagnose for AD is currently unknown, our findings suggest a potential use for circulating miRNAs, along with other markers, as non-invasive and relatively inexpensive biomarkers for the early diagnosis of AD, however, with further research and validation.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155483      PMCID: PMC3361462          DOI: 10.1016/j.expneurol.2011.11.026

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  64 in total

1.  Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.

Authors:  John P Cogswell; James Ward; Ian A Taylor; Michelle Waters; Yunling Shi; Brian Cannon; Kevin Kelnar; Jon Kemppainen; David Brown; Caifu Chen; Rab K Prinjha; Jill C Richardson; Ann M Saunders; Allen D Roses; Cynthia A Richards
Journal:  J Alzheimers Dis       Date:  2008-05       Impact factor: 4.472

Review 2.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

3.  Therapeutic effects of a ketogenic diet in Rett syndrome.

Authors:  R H Haas; M A Rice; D A Trauner; T A Merritt
Journal:  Am J Med Genet Suppl       Date:  1986

4.  Ketogenic diet in Rett syndrome.

Authors:  Gisela Maria Liebhaber; Edith Riemann; Friedrich Albert Matthias Baumeister
Journal:  J Child Neurol       Date:  2003-01       Impact factor: 1.987

5.  Cognitive deficits of men and women with Alzheimer's disease.

Authors:  V W Henderson; J G Buckwalter
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

6.  Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia.

Authors:  Yi Wen; Shaohua Yang; Ran Liu; Evelyn Perez; Kun Don Yi; Peter Koulen; James W Simpkins
Journal:  Brain Res       Date:  2004-05-22       Impact factor: 3.252

7.  Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.

Authors:  Rodney C Samaco; Raman P Nagarajan; Daniel Braunschweig; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2004-01-20       Impact factor: 6.150

8.  Gender differences in language of AD patients: a longitudinal study.

Authors:  D N Ripich; S A Petrill; P J Whitehouse; E W Ziol
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

9.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study.

Authors:  D L Bachman; P A Wolf; R Linn; J E Knoefel; J Cobb; A Belanger; R B D'Agostino; L R White
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

Review 10.  Alzheimer disease: operating characteristics of PET--a meta-analysis.

Authors:  Meenal B Patwardhan; Douglas C McCrory; David B Matchar; Gregory P Samsa; Olivier T Rutschmann
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

View more
  130 in total

Review 1.  Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Authors:  Ying Zi; Zhongmin Yin; Weizhong Xiao; Xinwei Liu; Zhixiang Gao; Li Jiao; Lianfu Deng
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Authors:  Marta Cosín-Tomás; Anna Antonell; Albert Lladó; Daniel Alcolea; Juan Fortea; Mario Ezquerra; Albert Lleó; Maria José Martí; Mercè Pallàs; Raquel Sanchez-Valle; José Luís Molinuevo; Coral Sanfeliu; Perla Kaliman
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

Review 3.  Exploring Biomarkers for Alzheimer's Disease.

Authors:  Neeti Sharma; Anshika Nikita Singh
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

Review 5.  Extracellular microRNA profiling in human follicular fluid: new biomarkers in female reproductive potential.

Authors:  Maryam Qasemi; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2020-07-09       Impact factor: 3.412

6.  MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.

Authors:  Theresa A Lusardi; Jay I Phillips; Jack T Wiedrick; Christina A Harrington; Babett Lind; Jodi A Lapidus; Joseph F Quinn; Julie A Saugstad
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?

Authors:  Juan F Codocedo; Juvenal A Ríos; Juan A Godoy; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2015-05-15       Impact factor: 5.590

8.  Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls.

Authors:  Lucía F Cardo; Eliecer Coto; Lorena de Mena; Renée Ribacoba; Germán Moris; Manuel Menéndez; Victoria Alvarez
Journal:  J Neurol       Date:  2013-03-30       Impact factor: 4.849

Review 9.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

10.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.